血塞通在23G微创玻切手术治疗糖尿病性玻璃体积血的作用

Effect of Xuesaitong on 23G Minimally Invasive Vitrectomy Operation in the Treatment of Diabetic Vitreous Hemorrhage

目的:探讨注射用血塞通(冻干粉)在23G微创玻切手术治疗糖尿病性玻璃体积血中的作用。方法:选取我院收治的2型糖尿病性玻璃体积血70例,将其随机分为两组,均给予常规血糖控制及23G微创玻切手术治疗,实验组于手术前给予注射用血塞通。对比两组患者的手术时间、术后并发症的发生率以及视力恢复情况。结果:实验组的平均手术时间明显短于对照组,术后出血、房性炎症、视网膜脱离、新生血管性青光眼并发症的发生率均明显低于对照组,差异有统计学意义(P<0.05);实验组视力恢复的总有效率显著高于与对照组,差异有统计学意义(P<0.05)。结论:术前应用注射用血塞通能够明显提高23G微创玻切手术治疗糖尿病性玻璃体积血的临床疗效,值得临床推广。

Objective： To explore the effect of Xuesaitong（lyophilized power）on 23 G minimally invasive vitrectomy operation in the treatment of diabetic vitreous hemorrhage. Methods： 70 cases of patients with type 2 diabetic vitreous hemorrhage who were treated in our hospital were selected and randomly divided into two groups. The patients in both groups were treated with normal blood glucose control and 23 g minimally invasive phaco surgical treatment. Besides, the patients in the experimental group were given blood flux injection before the surgery. Then the operation time, the incidence of postoperative complications and visual acuity of patients in the two groups were observed and compared. Results： The operation time of experimental group was significantly shorter than that of the control group, the incidence rates of hemorrhage, realinflammation, retinal detachment and neovascular glaucoma of experimental group were significantly lower than those of the control group, and the differences were statistically significant（P〈0.05）. The visual acuity of experimental group was better than that of the control group with statistically significant difference（P〈0.05）. Conclusions： Preoperative application of Xuesaitong injection could significantly improve the curative effect of 23 G minimally invasive vitrectomy operation in the treatment of diabetic vitreous hemorrhage, which was worthy of clinical promotion.